Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,471,163
  • Shares Outstanding, K 92,242
  • Annual Sales, $ 490,730 K
  • Annual Income, $ -25,550 K
  • EBIT $ -63 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.81
  • Price/Sales 5.22
  • Price/Cash Flow 76.63
  • Price/Book 21.62

Options Overview Details

View History
  • Implied Volatility 195.64% (-10.73%)
  • Historical Volatility 51.74%
  • IV Percentile 96%
  • IV Rank 85.76%
  • IV High 220.62% on 03/19/26
  • IV Low 45.18% on 09/19/25
  • Expected Move (DTE 22) 10.53 (38.21%)
  • Put/Call Vol Ratio 0.45
  • Today's Volume 87
  • Volume Avg (30-Day) 1,325
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 52,485
  • Open Int (30-Day) 68,073
  • Expected Range 17.03 to 38.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.24
  • Number of Estimates 7
  • High Estimate 0.15
  • Low Estimate -0.61
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +48.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.15 +5.39%
on 03/20/26
30.15 -8.59%
on 02/27/26
-1.78 (-6.07%)
since 02/25/26
3-Month
22.59 +22.00%
on 01/13/26
40.75 -32.37%
on 01/05/26
-12.72 (-31.58%)
since 12/24/25
52-Week
12.91 +113.48%
on 04/09/25
42.13 -34.58%
on 12/24/25
+6.55 (+31.18%)
since 03/25/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 29.03
2nd Resistance Point 28.31
1st Resistance Point 27.94
Last Price 27.56
1st Support Level 26.84
2nd Support Level 26.12
3rd Support Level 25.75

See More

52-Week High 42.13
Fibonacci 61.8% 30.97
Last Price 27.56
Fibonacci 50% 27.52
Fibonacci 38.2% 24.07
52-Week Low 12.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.